Replies to post #40623 on SiNtx Technologies Inc (SINT)

[boston745]

“I know some like to reference masks as a failure but its not; setback(?) maybe but not failure.” A SETBACK???!!! This is literally what everyone says, you’re incapable of having a shred of objectivity. Never seen anyone like you, fckin incredible

Looks like I was wrong on it even being a setback. It actually looks like the whole ordeal with O2 was actually a proof of concept collab that was intended to "fail" so the real collab could go on behind the scenes. Meanwhile "everyone" says the O2 & masks ordeal was a failure which I believe to be purposeful misrepresentation. Considering the evidence now, the whole "failure" rhetoric seems like people trying to con me and others which helped Anson and its conspiracy of funds heavily short SINT from 2H22 to 1H24. But I was the one not being objective...lol.

Dont agree with complete failure at all. In fact things just keep improving on the business front. I know some like to reference masks as a failure but its not; setback(?) maybe but not failure. IP has been developed further, thats a good thing and the IP is unencumbered for future collaborations.

I was incorrect in my statement of "future" collabs. There was already one or more collabs in place!

WHEN the mask thing first was announced I DID think this had great potential but then it fizzled; Bal raised decent funds 3x off of it, and went silent as usual afterwards. All that did was make me think even moreso, that he wasn't THAT serious about getting products to market in any timely manner, if at all....and here we are today.

Bal wasnt completely silent. There were Press Releases, two presentations in 2022/2024, and 10k's all that indicated that Bal was serious about getting masks to market, albeit certainly not timely and not with O2. The study mentioned in this press release was only recently published 4 years after they conducted the study. Meaning Sintx sat on and waited to publish it for years on purpose which aided the whole "failure" & "fizzle" narrative.

During recent months, research at the University of Rochester and at Virginia Polytechnic Institute and State University (Virginia Tech) has confirmed the earlier findings

In its testing, the Company found a consistent 3- to 4-log reduction (>99.9%) in viral loads; this occurred in less than 30 minutes, and in most cases, in less than 5 minutes. Nonwoven polypropylene fabrics embedded with both AP2 and AP4 silicon nitride powders were also effective against the newer SARS-CoV-2 variants, when tested to ISO 18184 standards.

Here is mention of new partners in regards to PPE:

SINTX has maintained a focus on the key target markets for PPE, such as automotive air cabin filters, coatings, and surfaces, and continues to identify other new applications. Because of the early stage of discussions and non-disclosure agreements, SINTX cannot disclose specific partners in some cases.

O2 collab "failure" (intentional) opened the door for this:

New opportunities in protective face masks and mask filters have come forward given the recent announcement to reassess the relationship with O2TODAY.

By March 2022 Sintx presentation indicated a confidential partnership in regards to PPE was already in place:



Quote Souces:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173996951
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173984699
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173147078
https://www.globenewswire.com/news-release/2021/08/18/2282785/30038/en/SINTX-Technologies-Provides-Update-on-Antipathogenic-Business-Segment.html
https://web.archive.org/web/20220327020051/https://4320147.fs1.hubspotusercontent-na1.net/hubfs/4320147/sintx/412073%20-%20SINTX%20Corporate%20Overview%20-%20R4.pdf